PLoS Genetics (Jun 2011)

SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.

  • Glenn M Marshall,
  • Pei Y Liu,
  • Samuele Gherardi,
  • Christopher J Scarlett,
  • Antonio Bedalov,
  • Ning Xu,
  • Nuncio Iraci,
  • Emanuele Valli,
  • Dora Ling,
  • Wayne Thomas,
  • Margo van Bekkum,
  • Eric Sekyere,
  • Kacper Jankowski,
  • Toby Trahair,
  • Karen L Mackenzie,
  • Michelle Haber,
  • Murray D Norris,
  • Andrew V Biankin,
  • Giovanni Perini,
  • Tao Liu

DOI
https://doi.org/10.1371/journal.pgen.1002135
Journal volume & issue
Vol. 7, no. 6
p. e1002135

Abstract

Read online

The N-Myc oncoprotein is a critical factor in neuroblastoma tumorigenesis which requires additional mechanisms converting a low-level to a high-level N-Myc expression. N-Myc protein is stabilized when phosphorylated at Serine 62 by phosphorylated ERK protein. Here we describe a novel positive feedback loop whereby N-Myc directly induced the transcription of the class III histone deacetylase SIRT1, which in turn increased N-Myc protein stability. SIRT1 binds to Myc Box I domain of N-Myc protein to form a novel transcriptional repressor complex at gene promoter of mitogen-activated protein kinase phosphatase 3 (MKP3), leading to transcriptional repression of MKP3, ERK protein phosphorylation, N-Myc protein phosphorylation at Serine 62, and N-Myc protein stabilization. Importantly, SIRT1 was up-regulated, MKP3 down-regulated, in pre-cancerous cells, and preventative treatment with the SIRT1 inhibitor Cambinol reduced tumorigenesis in TH-MYCN transgenic mice. Our data demonstrate the important roles of SIRT1 in N-Myc oncogenesis and SIRT1 inhibitors in the prevention and therapy of N-Myc-induced neuroblastoma.